Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 8
Submit an article Journal homepage
273
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Treatment patterns and outcomes with subcutaneous bortezomib in patients with relapsed mantle cell lymphoma: a retrospective, observational study of patient medical records from US community oncology practices

Alan P. SkarbnikLymphoma Division, Blood and Marrow Transplantation Program, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA; Correspondence[email protected]
,
Esprit MaMillennium Pharmaceuticals Inc, Cambridge, MA, USA;
,
Marie-Hélène LafeuilleGroupe d’analyse, Ltée, Montreal, QC, Canada;
,
Jonathan FortierGroupe d’analyse, Ltée, Montreal, QC, Canada;
,
Tatyana FeldmanLymphoma Division, Blood and Marrow Transplantation Program, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA;
,
Mei Sheng DuhAnalysis Group, Inc, Boston, MA, USA
,
Helgi van de VeldeMillennium Pharmaceuticals Inc, Cambridge, MA, USA;
,
Liviu NiculescuMillennium Pharmaceuticals Inc, Cambridge, MA, USA;
,
Vijayveer BonthapallyMillennium Pharmaceuticals Inc, Cambridge, MA, USA;
&
André GoyLymphoma Division, Blood and Marrow Transplantation Program, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA;
show all
Pages 1968-1972 | Received 19 Apr 2016, Accepted 11 Dec 2016, Published online: 16 Jan 2017

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Claire L. Simons, Daniel Malone, Michael Wang, Gregory A. Maglinte, Tim Inocencio, Sally W. Wade, Craig Bennison & Bijal Shah. (2021) Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States. Journal of Medical Economics 24:1, pages 421-431.
Read now

Articles from other publishers (2)

Noa Biran,Pooja Phull,andand & Andre Goy. 2023. Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies. Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies 331 360 .
Stephen Jolles, Sergio Giralt, Tessa Kerre, Hillard M. Lazarus, S. Shahzad Mustafa, Roberto Ria & Donald C. Vinh. (2023) Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review. Frontiers in Oncology 13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.